Form D · Other

VIOME LIFE SCIENCES, INC.

Bellevue, WA · CIK 0001711837

Offering snapshot reported Aug 28, 2024 · SEC filing

Reported sold
$25.4M
Offering amount: $30M
Investors reported
44
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 19, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 28, 2024Initial$25,442,535No comparison44SEC filing
Oct 11, 2022Initial$67,004,494No comparison34SEC filing
Feb 11, 2021Initial$3,000,000No comparison2SEC filing
Nov 27, 2019Initial$36,463,122No comparison18SEC filing
Aug 2, 2018Amendment$14,600,000$9,100,000vs Jul 3, 20186SEC filing
Jul 3, 2018Initial$5,500,000No comparison2SEC filing
Jul 28, 2017Initial$15,000,002No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-522640

Source: Form D, filed Aug 28, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Erik Anderson Director
Teymour Boutros Ghali Director
Naveen K Jain Director, Executive
Eiichiro Kimura Director
Christopher Kitze Director
George Montgomery Director
Gregory J. Moore Director
Alex Morgan Director
William A. Owens Director
Steven W. Sansom Director
Deepak Savadatti Executive

Issuer details

Industry: Other (See others in industry)

Address:
205 108 Th Ave Ne, Suite 150
Bellevue, WA, 98004